ArticleInternational journal of clinical and experimental pathology2019
Indolent T-lymphoblastic proliferation associated with Castleman disease and low grade follicular dendric cell sarcoma: report of a case and review of literature.
Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
- Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature.Journal of hematopathology · 2023Review
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.Leukemia · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Indolent T-lymphoblastic proliferation (IT-LBP) is referred to as extrathymic immature TDT+T-cell hyperplasia, non-neoplastic lesion, often misdiagnosed as T-lymphoblastic lymphoma and overtreated. We report a case of a 20-year-old male patient with a right adrenal gland mass, diagnosed as indolent T-lymphoblastic proliferation (IT-LBP) associated with hyaline vascular Castleman disease (HV-CD) and low grade follicular dendric cell sarcoma (LG-FDCS). The case is a rare combination of finding, and it is the first case occurring in adrenal gland. IT-LBP is a clinically indolent disease, requiring no treatment, often associated with other tumors. Because of the high ki67 index, IT-LBP is easily misdiagnosed as T-lymphoblastic lymphoma, causing overtreatment. Understanding the biological behavior, treatment, prognosis and the associated diseases of IT-LBP is important.
Indexed as
Identifiers
31933967PMC6947067W3005725420What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.